These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15288408)

  • 41. Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs.
    Wienecke T; Olesen J; Ashina M
    Cephalalgia; 2010 Feb; 30(2):179-90. PubMed ID: 19614689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calcitonin gene-related peptide induced migraine attacks in patients with and without familial aggregation of migraine.
    Guo S; Christensen AF; Liu ML; Janjooa BN; Olesen J; Ashina M
    Cephalalgia; 2017 Feb; 37(2):114-124. PubMed ID: 26994300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Normobaric hypoxia and nitroglycerin as trigger factors for migraine.
    Schoonman GG; Sándor PS; Agosti RM; Siccoli M; Bärtsch P; Ferrari MD; Baumgartner RW
    Cephalalgia; 2006 Jul; 26(7):816-9. PubMed ID: 16776696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Episodic dural stimulation in awake rats: a model for recurrent headache.
    Oshinsky ML; Gomonchareonsiri S
    Headache; 2007; 47(7):1026-36. PubMed ID: 17635594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amplification of glyceryl trinitrate-induced headache features by noxious craniofacial stimuli in pain-free healthy humans.
    Gazerani P; Cairns BE; Yassin H; Yousefi JT; Sherzaman AR; Nedergaard BS; Boldsen SK
    Pain Manag; 2019 Jan; 9(1):17-35. PubMed ID: 30501556
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interrelations between migraine and tension-type headache in the general population.
    Rasmussen BK; Jensen R; Schroll M; Olesen J
    Arch Neurol; 1992 Sep; 49(9):914-8. PubMed ID: 1520080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Migraine and tension-type headache in Croatia: a population-based survey of precipitating factors.
    Zivadinov R; Willheim K; Sepic-Grahovac D; Jurjevic A; Bucuk M; Brnabic-Razmilic O; Relja G; Zorzon M
    Cephalalgia; 2003 Jun; 23(5):336-43. PubMed ID: 12780762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nitric oxide modulation of low-frequency oscillations in cortical vessels in FHM--a NIRS study.
    Schytz HW; Hansen JM; Phillip D; Selb J; Boas DA; Ashina M
    Headache; 2012; 52(7):1146-54. PubMed ID: 22352839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prodromes and the early phase of the migraine attack: therapeutic relevance.
    Buzzi MG; Cologno D; Formisano R; Rossi P
    Funct Neurol; 2005; 20(4):179-83. PubMed ID: 16483458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine.
    Greco R; Ferrigno A; Demartini C; Zanaboni A; Mangione AS; Blandini F; Nappi G; Vairetti M; Tassorelli C
    J Headache Pain; 2015; 16():560. PubMed ID: 26272684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Headache characteristics during the development of tolerance to nitrates: pathophysiological implications.
    Christiansen I; Iversen HK; Olesen J
    Cephalalgia; 2000 Jun; 20(5):437-44. PubMed ID: 11037739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Towards a reliable animal model of migraine.
    Olesen J; Jansen-Olesen I
    Cephalalgia; 2012 May; 32(7):578-80. PubMed ID: 22451494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of interaction between a polymorphism in the dopamine D2 receptor gene and the clinical features of migraine.
    Rebaudengo N; Rainero I; Parziale A; Rosina F; Pavanelli E; Rubino E; Mazza C; Ostacoli L; Furlan PM
    Cephalalgia; 2004 Jun; 24(6):503-7. PubMed ID: 15154861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abnormal cardiovascular response to nitroglycerin in migraine.
    van Oosterhout WP; Schoonman GG; Saal DP; Thijs RD; Ferrari MD; van Dijk JG
    Cephalalgia; 2020 Mar; 40(3):266-277. PubMed ID: 31594384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches.
    Sances G; Tassorelli C; Pucci E; Ghiotto N; Sandrini G; Nappi G
    Cephalalgia; 2004 Feb; 24(2):110-9. PubMed ID: 14728706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine.
    Guo S; Vollesen ALH; Olesen J; Ashina M
    Pain; 2016 Dec; 157(12):2773-2781. PubMed ID: 27842045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of migraine-like headache, but not aura, by cilostazol in patients with migraine with aura.
    Butt JH; Rostrup E; Hansen AS; Lambertsen KL; Kruuse C
    Brain; 2018 Oct; 141(10):2943-2951. PubMed ID: 30137217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. No central action of CGRP antagonising drugs in the GTN mouse model of migraine.
    Christensen SL; Ernstsen C; Olesen J; Kristensen DM
    Cephalalgia; 2020 Aug; 40(9):924-934. PubMed ID: 32223300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hungarian migraine epidemiology.
    Bánk J; Márton S
    Headache; 2000 Feb; 40(2):164-9. PubMed ID: 10759917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A nosographic analysis of the migraine aura in a general population.
    Russell MB; Olesen J
    Brain; 1996 Apr; 119 ( Pt 2)():355-61. PubMed ID: 8800932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.